{"id":772302,"date":"2026-07-01T01:34:29","date_gmt":"2026-07-01T01:34:29","guid":{"rendered":"https:\/\/www.newsbeep.com\/ca\/772302\/"},"modified":"2026-07-01T01:34:29","modified_gmt":"2026-07-01T01:34:29","slug":"is-medtronic-plc-mdt-a-good-stock-to-buy-now","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/ca\/772302\/","title":{"rendered":"Is Medtronic plc (MDT) A Good Stock To Buy Now?"},"content":{"rendered":"\n

Is MDT a good stock to buy? We came across a\u00a0bullish thesis\u00a0<\/a>on Medtronic plc on TheDividendPrince’s Substack. In this article, we will summarize the bulls’ thesis on MDT. Medtronic plc’s share was trading at $80.98 as of June 26th. MDT’s trailing and forward P\/E were 21.71 and 13.59 respectively according to Yahoo Finance. <\/p>\n

\"Jim<\/a> Jim Cramer on Butterfly Network (BFLY): \u201cToo Hard for This Guy, Just Too Hard\u201d <\/p>\n

Serhii Bobyk\/Shutterstock.com <\/p>\n

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. MDT is positioned as a Dividend Aristocrat with more than 25 consecutive years of dividend increases, reflecting a durable shareholder return framework supported by resilient cash flows and diversified healthcare exposure. <\/p>\n

Read More:\u00a015 AI Stocks That Are Quietly Making Investors Rich<\/a> <\/p>\n

Read More:\u00a0Undervalued AI Stock Poised For Massive Gains: 10000% Upside Potential<\/a> <\/p>\n

The company offers a 3.54 percent dividend yield with a $2.84 annual dividend, underpinned by a Dividend Safety Rating of 75 out of 100, Safe, supported by strong fundamentals including a 2.5x current ratio, 63.8 percent gross margins, and a proven operating record. <\/p>\n

While its score is slightly lower relative to peers due to a higher debt load associated with its acquisition-driven strategy, Medtronic maintains a narrow economic moat driven by deep physician relationships, extensive intellectual property, and validated product portfolios. The bullish thesis is anchored in its growth drivers, particularly pulsed field ablation for atrial fibrillation and new hypertension therapies, which open large addressable markets and support sustained revenue expansion. <\/p>\n

Additionally, its pipeline across surgical robotics and cardiovascular innovation enhances long-term visibility. Although competitive pressure from Intuitive Surgical’s da Vinci platform and reimbursement constraints from Medicare represent structural headwinds, Medtronic’s scale, installed base, and innovation pipeline provide offsets. At $80 per share, the stock trades at a 27 percent discount to Morningstar’s $112 fair value estimate, implying significant upside potential. <\/p>\n

This valuation disconnect presents an attractive entry point for long-term investors seeking income capital appreciation. Overall, Medtronic represents a defensive yet growing healthcare compounder with durable dividends, improving product cycles, and meaningful rerating potential as new therapies scale and valuation normalizes over time. <\/p>\n

Previously, we covered a bullish thesis<\/a> on Medtronic plc (MDT) by Investing Intel’s Substack in May 2025, which highlighted strong FY2025 growth, cardiovascular and diabetes momentum, and a planned diabetes spin-off to unlock value. MDT’s stock price has been flat since our coverage. TheDividendPrince shares a similar view but emphasizes dividend durability, moat strength, and pipeline-led long-term compounding despite competitive and reimbursement headwinds. <\/p>\n","protected":false},"excerpt":{"rendered":"Is MDT a good stock to buy? We came across a\u00a0bullish thesis\u00a0on Medtronic plc on TheDividendPrince’s Substack. In…\n","protected":false},"author":2,"featured_media":772303,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[49,48,84,392,33522,51418],"class_list":["post-772302","post","type-post","status-publish","format-standard","has-post-thumbnail","category-healthcare","tag-ca","tag-canada","tag-health","tag-healthcare","tag-healthcare-systems","tag-medtronic"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/772302","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/comments?post=772302"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/posts\/772302\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media\/772303"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/media?parent=772302"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/categories?post=772302"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/ca\/wp-json\/wp\/v2\/tags?post=772302"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}